Saito Kenki 齋藤健貴

… Alternative Names

齋藤健貴サイトウケンキ

Less

Researcher Number	30972400
Other IDs
Affiliation (Current)	2026: 奈良県立医科大学, 医学部附属病院, 研究員
Affiliation (based on the past Project Information) *help	2023 – 2024: 奈良県立医科大学, 医学部附属病院, 研究員
Review Section/Research Field	Except Principal Investigator Basic Section 54010:Hematology and medical oncology-related
Keywords	Except Principal Investigator 動物疾患モデル / 動物モデル / 血栓性血小板減少性紫斑病

Development of an animal model of acquired thrombotic thrombocytopenic purpura
- Principal Investigator
  
  Matsumoto Masanori
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Nara Medical University

All 2025 2024 2023 2022

All Journal Article Presentation

[Journal Article] Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data2025
- Author(s)
  Sakai Kazuya、Hamamura Atsushi、Yoshimura Yoshiko、Abe Miyuki、Ogawa Yoshiyuki、Tanaka Kazuki、Hattori Norimichi、Tokugawa Tazuko、Kanai Rie、Ikejiri Fumiyoshi、Takeyama Masahiro、Taoka Teruhisa、Fujita Naoki、Kanaya Minoru、Koh Katsuyoshi、Shiragami Hiroshi、Azumi Hidekazu、Saito Kenki、Matsumoto Masanori
- Journal Title
  
  Blood
  
  Volume: 145 Issue: 20 Pages: 2390-2395
- DOI
  10.1182/blood.2024027516
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08461, KAKENHI-PROJECT-23K25186
[Journal Article] Persistent ADAMTS13 Inhibitor Delays Recovery of ADAMTS13 activity in Caplacizumab-Treated Japanese iTTP Patients2024
- Author(s)
  Saito Kenki、Sakai Kazuya、Kubo Masayuki、Azumi Hidekazu、Hamamura Atsushi、Ochi Shinichi、Amagase Hiroki、Kunieda Hisako、Ogawa Yoshiyuki、Yagi Hideo、Matsumoto Masanori
- Journal Title
  
  Blood Advances
  
  Volume: 2024 Issue: 9 Pages: 2151-2159
- DOI
  10.1182/bloodadvances.2023012451
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K25186, KAKENHI-PROJECT-22K08461
[Presentation] Recurrent thrombocytopenia during caplacizumab treatment in patients with acute immune-mediated thrombotic thrombocytopenic purpura after the clinical response.2024
- Author(s)
  16.Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Masanori Matsumoto.
- Organizer
  32nd Congress of the International Society on Thrombosis and Haemostasis
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08461
[Presentation] Immediate Therapeutic Intervention for Acute Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura with Positive Chest Findings at Initial Presentation.2024
- Author(s)
  Atsushi Hamamura, Kazuya Sakai, Toshiki Mushino, Yasunori Ueda, Yoshiyuki Ogawa, Hiroyuki Noguchi, Akinao Okamoto, Hisako Kunieda, Shinichi Ochi, Takashi Onaka, Daichi Nishiyama, Nobuhiko Uoshima, Yasuyuki Arai, Akira Matsumoto, Kenki Saito, Hidekazu Azumi, Masayuki Kubo, Hideo Yagi, Takashi Sonoki, Masanori Matsumoto.
- Organizer
  66th ASH Annual Meeting.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08461
[Presentation] 695 Persistent ADAMTS13 Inhibitor May Lead to Delayed ADAMTS13 Recovery in Japanese Patients with Caplacizumab-Treated Immune-Mediated Thrombotic Thrombocytopenic Purpura.2023
- Author(s)
  Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Shinichi Ochi, Shinya Kobayashi, Hideo Yagi, Masanori Matsumoto.
- Organizer
  The 66th ASH Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08461
[Presentation] Differential Diagnosis Distinguishing Immune TTP from Septic DIC Using Plasma Levels of Haptoglobin and Factor XIII Activity.2022
- Author(s)
  Shinya Yamada, Masayuki Kubo, Eriko Hamada, Kenki Saito, Masaki Hayakawa, Hidesaku Asakura, Masanori Matsumoto.
- Organizer
  64th ASH Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08461

1. Matsumoto Masanori (60316081)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
2. 早川正樹 (30516729)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
3. 久保政之 (40646080)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
4. 山田真也 (50927803)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

Saito Kenki 齋藤健貴

齋藤健貴サイトウケンキ

Research Projects

Research Products

Co-Researchers

Development of an animal model of acquired thrombotic thrombocytopenic purpura

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data2025

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Persistent ADAMTS13 Inhibitor Delays Recovery of ADAMTS13 activity in Caplacizumab-Treated Japanese iTTP Patients2024

Author(s)

Journal Title

DOI

Data Source

[Presentation] Recurrent thrombocytopenia during caplacizumab treatment in patients with acute immune-mediated thrombotic thrombocytopenic purpura after the clinical response.2024

Author(s)

Organizer

Data Source

[Presentation] Immediate Therapeutic Intervention for Acute Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura with Positive Chest Findings at Initial Presentation.2024

Author(s)

Organizer

Data Source

[Presentation] 695 Persistent ADAMTS13 Inhibitor May Lead to Delayed ADAMTS13 Recovery in Japanese Patients with Caplacizumab-Treated Immune-Mediated Thrombotic Thrombocytopenic Purpura.2023

Author(s)

Organizer

Data Source

[Presentation] Differential Diagnosis Distinguishing Immune TTP from Septic DIC Using Plasma Levels of Haptoglobin and Factor XIII Activity.2022

Author(s)

Organizer

Data Source

Saito Kenki 齋藤 健貴

齋藤 健貴 サイトウ ケンキ

Research Projects

Research Products

Co-Researchers

Development of an animal model of acquired thrombotic thrombocytopenic purpura

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data2025

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Persistent ADAMTS13 Inhibitor Delays Recovery of ADAMTS13 activity in Caplacizumab-Treated Japanese iTTP Patients2024

Author(s)

Journal Title

DOI

Data Source

[Presentation] Recurrent thrombocytopenia during caplacizumab treatment in patients with acute immune-mediated thrombotic thrombocytopenic purpura after the clinical response.2024

Author(s)

Organizer

Data Source

[Presentation] Immediate Therapeutic Intervention for Acute Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura with Positive Chest Findings at Initial Presentation.2024

Author(s)

Organizer

Data Source

[Presentation] 695 Persistent ADAMTS13 Inhibitor May Lead to Delayed ADAMTS13 Recovery in Japanese Patients with Caplacizumab-Treated Immune-Mediated Thrombotic Thrombocytopenic Purpura.2023

Author(s)

Organizer

Data Source

[Presentation] Differential Diagnosis Distinguishing Immune TTP from Septic DIC Using Plasma Levels of Haptoglobin and Factor XIII Activity.2022

Author(s)

Organizer

Data Source

Saito Kenki 齋藤健貴

齋藤健貴サイトウケンキ